Institute For Medical Aesthetics is categorized under Ear Nose and Throat Doctors in Wilmington, DE and active since 1997.
Institute For Medical Aesthetics was established in 1997, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Ear Nose and Throat Doctors business, which does work in the B2C market, and is classified as a Ear Nose and Throat Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Beth Mizerny at the company’s single location by writing to 509 Falkirk Road, Wilmington, Delaware DE 19803 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Institute For Medical Aesthetics |
| Contact Person: | Beth Mizerny |
| Address: | 509 Falkirk Road, Wilmington, Delaware 19803 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ear Nose and Throat Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Institute For Medical Aesthetics was started in 1997 to provide professional Ear Nose and Throat Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Beth Mizerny for inquiries that concern Institute For Medical Aesthetics by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Institute For Medical Aesthetics can be found at the coordinates 39.79506,-75.563171 as well as the street address 509 Falkirk Road in Wilmington, Delaware 19803.
For its online presence, you may visit Institute For Medical Aesthetics’s website at and engage with its social media outlets through on Twitter and on Facebook.